Synthesis and Crystal Structure of 3,3,6,6-Tetramethylmorpholine-2,5-dione, and its 5-Monothio- and 2,5-Dithio-Derivatives by Mawad, N et al.
University of Zurich
Zurich Open Repository and Archive
Winterthurerstr. 190
CH-8057 Zurich
http://www.zora.uzh.ch
Year: 2010
Synthesis and Crystal Structure of
3,3,6,6-Tetramethylmorpholine-2,5-dione, and its 5-Monothio-
and 2,5-Dithio-Derivatives
Mawad, N; Ghorbani-Salman Pour, F; Linden, A; Heimgartner, H
Mawad, N; Ghorbani-Salman Pour, F; Linden, A; Heimgartner, H (2010). Synthesis and Crystal Structure of
3,3,6,6-Tetramethylmorpholine-2,5-dione, and its 5-Monothio- and 2,5-Dithio-Derivatives. Helvetica Chimica Acta,
93(12):2326-2346.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Helvetica Chimica Acta 2010, 93(12):2326-2346.
Mawad, N; Ghorbani-Salman Pour, F; Linden, A; Heimgartner, H (2010). Synthesis and Crystal Structure of
3,3,6,6-Tetramethylmorpholine-2,5-dione, and its 5-Monothio- and 2,5-Dithio-Derivatives. Helvetica Chimica Acta,
93(12):2326-2346.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Helvetica Chimica Acta 2010, 93(12):2326-2346.
Synthesis and Crystal Structure of
3,3,6,6-Tetramethylmorpholine-2,5-dione, and its 5-Monothio-
and 2,5-Dithio-Derivatives
Abstract
The synthesis of 3,3-dimethylmorpholine-2,5-diones 4a was achieved conveniently via the ‘direct amide
 cyclization' of the linear precursors of type 3, which were prepared by the coupling of
2,2-dimethyl-2H-azirin-3-amines 2 with 2-hydroxyalkanoic acids 1. Thionation of 4a with Lawesson's
reagent yielded the corresponding 5-thioxomorpholin-2-ones 10 and morpholine-2,5-dithiones 11,
respectively, depending on the reaction conditions. The structures of 3aa, 4aa, 10a and 11a were
established by X-ray crystallography. All attempts to prepare S-containing morpholine-2,5-dione
analogs or thiomorpholine-2,5-diones by cyclization of corresponding S-containing precursors were
unsuccessful and led to various other products. The structures of some of them have also been
established by X-ray crystallography.
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2The synthesis  of  3,3-dimethylmorpholine-2,5-diones  4a  was achieved conveniently 
via the ‘direct amide  cyclization’ of the linear precursors of type 3, which were prepared by 
the  coupling  of  2,2-dimethyl-2H-azirin-3-amines  2 with  2-hydroxyalkanoic  acids  1. 
Thionation of  4a with  Lawesson’s reagent yielded the corresponding 5-thioxomorpholin-2-
ones 10 and morpholine-2,5-dithiones 11, respectively, depending on the reaction conditions. 
The  structures  of  3a,  4aa, 10a and  11a were  established  by  X-ray  crystallography.  All 
attempts to prepare sulfur-containing morpholine-2,5-dione analogues or thiomorpholine-2,5-
diones by cyclization of corresponding S-containing precursors were unsuccessful and led to 
various other products. The structures of some of them have also been established by X-ray 
crystallography.
3Introduction. – In the last  30 years,  we have demonstrated that  the ‘direct  amide 
cyclization’ [1] is a useful method for the synthesis of cyclodepsipeptides, which contain α,α-
disubstituted α-amino acids, e.g., α-aminoisobutyric acid (Aib) [2]. The combination with the 
‘azirine/oxazolone method’ [3] for the preparation of the linear precursors offers a convenient 
and efficient access to this class of compounds. For example, the reaction sequence starting 
with an α-hydroxy acid 1 and azirine 2a yielding compound 3 (n = 1), followed by repeated 
hydrolysis and azirine coupling, and finally cyclization leads to cyclodepsipeptides of type 4 
with 6-, 9-, 12-, and 15-membered rings [1b] (Scheme 1). Analogously, 16- and 19-membered 
cyclodepsipeptides are accessible from β-hydroxy acids [4]. Furthermore, cyclodepsipeptides 
with  an  alternating  sequence  of  α-hydroxy-  and  α,α-disubstituted  α-amino  acids  can  be 
prepared by coupling segments of type 3, followed by ‘direct amide cyclization’ [1c][5].
Scheme 1
The  synthesis  and  stability  of  morpholine-2,5-diones  (4a),  which  are  the  smallest 
cyclodepsipeptides, has been studied already 60 years ago [6]. But only in the last couple of 
years have these compounds gained increasing interest as natural products [7], biologically 
active compounds [8], and particularly as monomers of biodegradable polymers [9]. There are 
three  types  of  cyclization  known  leading  to  4a,  i.e.,  lactonization,  lactamization,  and 
cyclization of  N-(2-bromoacetyl)glycine sodium salts (for reviews see [10]). In the case of 
α,α-disubstituted  glycines,  a  very  simple  and  efficient  protocol  is  the  ‘direct  amide 
cyclization’ of 3 (n = 1) [1b]. Surprisingly, all attempts to prepare the analogous 7-membered 
1,4-oxazepine-2,5-diones  5 by  the  same  method  failed,  and  only  the  14-membered 
cyclodimers were obtained [11].
4In connection with our interest in heterocyclic thiones, e.g., 1,3-thiazole-5(4H)-thiones 
6 [12],  5,5-dimethyl-3-methylidenpyrrolidine-2-thione  (7)  [13],  5-benzylidene-3-
phenylrhodanine  (8)  [14],  and  imidazole-2-thiones  9 [15],  we  became  interested  in 
thioanalogues of morpholine-2,5-diones. Therefore, we studied various reactions toward the 
only scarcely known mono-  and dithioxomorpholines  of  type  5 and  6.  Besides  attempted 
cyclizations of thioxoderivatives of 3a (n = 1), the stepwise thionation of 4a with Lawesson’s 
reagent [16] to yield 5-thioxomorpholin-2-ones (10) and morpholine-2,5-dithiones (11) was 
investigated. 
Formulae 6 – 9
Results and Discussion. –  Synthesis and Thionation of Morpholine-2,5-diones. The 
reaction of α-hydroxy acids 1a – 1c with 2,2,N-trimethyl-N-phenyl-2H-azirin-3-amine (2b) in 
MeCN at 0° → room temperature led to the diamides 3aa – 3ac in 95 – 96% yield (Scheme 
2), in accordance with the general reactivity of 2H-azirin-3-amines [3a]. In comparison with 
the reactions of the corresponding 2,2,N,N-tetramethyl-2H-azirin-3-amines [17], the reaction 
times  were  longer  but  the  yields  were  higher.  The  structures  of  the  products  have  been 
established  on  the  basis  of  their  spectroscopic  data  and,  in  the  case  of  3aa,  by  X-ray 
crystallography (Fig. 1).
Scheme 2
Fig. 1. ORTEP Plot [18] of the molecular structure of 3aa (50% probability ellipsoids, 
arbitrary numbering of the atoms)
5The conformation of 3aa is as expected for peptides containing Aib [19]: the torsion 
angles φ (C(2)-C(3)-N(4)-C(5)) and ψ (N(1)-C(2)-C(3)-N(4)) of the Aib unit are –46.1(3) and 
–49.0(3)°, respectively, i.e., close to the values for helical peptide structures (e.g. ca. –47 and 
–57° for the α-helix). Both amide groups are almost planar (C(3)-C(2)-N(1)-C(7): 178.6(2)°; 
C(3)-N(4)-C(5)-C(6):  –175.8(2)°),  but  the  orientation  of  the  Ph  ring  at  N(1)  is  nearly 
orthogonal to the plane of the amide group (C(2)-N(1)-C(7)-C(8): –99.9(2)°). The N(4)–H 
group forms an intramolecular H-bond with the O(6)-atom of the OH group, thereby forming 
a five-membered loop with a graph set motif [20] of S(5). As a result, the torsion angle N(4)-
C(5)-C(6)-O(6) is 9.5(3)°. The OH group forms an intermolecular H-bond with the amide 
O(5)-atom of a neighboring molecule,  thereby linking the molecules into one-dimensional 
chains which run parallel to the [100] direction and have a graph set motif of C(5).
The  cyclization  of  3aa –  3ac to  give  the  morpholine-2,5-diones  4aa –  4ac was 
performed  following  a  previously  described  protocol  [1b]:  a  stirred  suspension3) of  the 
diamides in dry toluene was heated to 90 – 100°, and a stream of dry HCl gas was bubbled 
through  the  solution  for  10  –  30  min.  After  removing  the  precipitated  N-methylaniline 
hydrochloride and purification of the product by crystallization or chromatography, 4aa – 4ac 
[1b] were obtained in 61, 27, and 22% yield, respectively (Scheme 2)4). The elucidation of the 
structures was based on the spectroscopic5) and analytical data and, in the cases of 4aa (Fig.  
2a) and 4ab [21], the structures were confirmed by X-ray crystallography.
3 ) At the reaction temperature of ca. 100°, the diamides of type 3 were dissolved. 
4 ) The cyclization of the corresponding N,N-dimethyl derivatives 3 (n = 1) yielded the 
morpholin-2,5-diones 4aa – 4ac in 87, 30, and 75% yield, respectively [1b].
5 ) The previously reported 13C chemical shift of C(2) of 4ac proved to be incorrect. The 
absorption signals of the two C=O groups appear at 169.1 and 165.3 ppm (Table 1).
6Conceivable intermediates for the acid-catalyzed cyclization of  3 to  4 are shown in 
Scheme 2 (see also [1b]). In analogy to previously described ‘direct amide cyclizations’, we 
propose  that  the  first  step is  the  formation  of  a  1,3-oxazol-5(4H)-one  A [2].  Whereas  in 
analogous intermediates with a longer tether between the oxazolone ring and the nucleophilic 
group the attack  at  C(5)  may occur  directly,  this  seems not  possible  in  the  present  case. 
Therefore, the ring opening to give the acylium ion  B, which cyclizes  via formation of the 
lactone group, is a likely process.
The thionation of morpholine-2,5-diones 4aa – 4ac with 0.5 equiv. Lawesson reagent 
(L.R.; 2,4-bis(4-methoxyphenyl)-1,3,2,4-dithiadiphosphetane 2,4-disulfide) in toluene at 90 – 
100° for 20 – 30 min gave the thiolactams 10a – 10c in 68 – 98% yield as the sole products 
(Scheme  3).  The  observed  selectivity  reflects  the  generally  known  reactivity  of  C=O 
compounds on thionations with L.R. [16], i.e., thionations of amides (lactams) are faster than 
those of esters (lactones). The structures have been deduced from the spectroscopic data. The 
most characteristic differences to those of 4aa – 4ac, in addition to elemental analyses, are the 
missing C=O absorption at ca. 1680 cm–1 in the IR spectrum and the absorption of C(5)=S at 
193 – 200 ppm in the  13C-NMR spectrum (Table 1).  Furthermore,  X-ray crystal-structure 
determinations were performed in the cases of 10a (Fig. 2b) and 10b [21].
Scheme 3
Table 1. Characteristic Spectroscopic Data of Compounds 4a, 10, and 11
The thionation of the lactone group of  10a and  10b has been achieved under more 
drastic conditions [22]: suspensions of  10a and  10b and 2.5 equiv. of  L.R. in toluene were 
heated to reflux for 2 – 6 d leading to morpholine-2,5-dithiones 11a and 11b in 49 and 28% 
7yield, respectively, as yellow crystalline materials. Again, the structures have been determined 
on  the  basis  of  the  spectroscopic  data  (Table  1)  and  proved  by  X-ray  crystal-structure 
determinations (11a (Fig. 2c), 11b [21]).
Fig. 2. ORTEP Plots [18] of the molecular structures of a) 4aa, b) 10a (polymorph 1), 
and c) 11a (50% probability ellipsoids, arbitrary numbering of the atoms)
The six-membered rings of 4aa and 10a (polymorph 1) have a conformation midway 
between  that  of  a  highly  flattened  boat  and  a  twist-boat,  where  C(6)  shows  the  most 
significant deviation from the ring plane. The N(4)–H group forms an intermolecular H-bond 
with the amide O(5)-atom and the S(5)-atom, respectively, of a neighboring molecule. This 
interaction  forms  closed loops  and thereby links  pairs  of  molecules  into  centrosymmetric 
dimers,  which have a graph set  motif  [20] of R22(8) (for a  similar  structure see [21]).  In 
another crystallization of  10a, a second polymorph was obtained, in which two symmetry-
independent molecules are in the asymmetric unit. The six-membered ring in each molecule 
has a flattened boat conformation. The N–H group in molecule A forms an intermolecular H-
bond with the S-atom of a neighboring molecule A. This interaction forms closed loops and 
thereby links pairs of molecules of type A into centrosymmetric dimers, which have a graph 
set motif of R22(8). The molecules of type B form the same type of centrosymmetric dimers.
In the dithione  11a, the molecule sits across a crystallographic centre of inversion. 
Thus the O- and NH groups are necessarily disordered in the model with equal site occupation 
factors  of  0.5.  The  proximity  of  the  N-  and  O-atoms  in  the  model  makes  it  difficult  to 
accurately refine their positions. Therefore, some of the bond lengths involving these atoms 
are only approximate and a reliable analysis of the ring conformation is not practicable. The 
N(4)–H group forms an intermolecular H-bond with the S(2)-atom of a neighboring molecule. 
8This interaction links the molecules into infinite one-dimensional chains, which run parallel to 
the [101] direction and have a graph set motif of C(5). The centrosymmetric disorder in the 
molecules  results  in  these  chains  also  being  disordered,  running  in  one  direction  in  one 
orientation of the disorder and in the opposite direction in the alternate disordered orientation.
Attempted Cyclizations of Sulfur-Containing Diamides. In the past we have shown that 
the reaction of 2H-azirin-3-amines of type 2 with thioacids 12 leads to monothiodiamides 13 
with a terminal thioamide group [23] (Scheme 4). Under acidic conditions, the latter cyclize to 
form 1,3-oxathiazole-5(4H)-thiones  14, which undergo a spontaneous isomerization to yield 
1,3-thiazol-5(4H)-ones 15. Treatment of 15 with Me2NH gave the monothiodiamides of type 
16 (R1 =  R2 =  Me).  Under  modified  conditions,  a  one-pot  isomerization  13 → 16 was 
elaborated.  This  reaction  sequence was used for  the selective  synthesis  of Aib-containing 
endothiopeptides [23d][24].
Scheme 4
In a previous paper [23d], we described the acid-catalyzed reactions of compounds 17 
(R = tBu, THP). Whereas the treatment of a solution of 17a (R = tBu) in dry toluene at 80° 
with HCl gas for two min gave the isomeric product 18a in 53% yield, an analogous reaction 
(30 min, 90°) led to a mixture of 1,3-thiazol-5(4H-one 19a (60%) and 2-thioxomorpholin-5-
one 20 (6%, Scheme 5). The latter was obtained in 30% yield  via deprotection of the THP-
derivative 17b (R = THP) and subsequent acid-catalyzed cyclization (toluene, 90°, HCl gas).
Scheme 5
9With  these  results  in  mind,  we  attempted  the  synthesis  of  sulfur-analogues  of 
morpholine-2,5-diones via acid-catalyzed cyclization of suitable S-containing precursors. In a 
first experiment, the crude THP-protected mandelic thioacid 21 was reacted with azirine 2b to 
give  the  desired  monthiodiamide  22 in  52% yield  (Scheme  6).  As  an  unexpected  minor 
product  (20%),  23 was  obtained,  the  structure  of  which  was  established  by  X-ray 
crystallography (Fig. 3). Since the space group is centrosymmetric, the crystals are racemic. 
The amide  NH group forms an intramolecular  H-bond with O(7) of the carbonate  group, 
thereby forming a five-membered ring with a graph set motif of S(5)6).
Scheme 6
Fig. 3. ORTEP Plot [18] of the molecular structure of 23 (50% probability ellipsoids, 
arbitrary numbering of the atoms)
Deprotection of  22 to give  24 was achieved in quantitative yield by treatment with 
pyridinium para-toluene sulfonate (PPTS) in EtOH (Scheme 6). With the aim of preparing the 
2-thioxomorpholin-5-one 20 (Scheme 5), HCl gas was bubbled through a solution of 24 in dry 
toluene at 100–110° for 20 min, leading to a complex mixture of products. Chromatographic 
workup gave, in addition to 33% of the starting material 24, three isomeric products in ca. 26, 
12,  and  6%  yield,  with  the  mass  of  the  expected  20 (ESI-MS:  m/z [M+1]+ =  236). 
Unfortunately, the spectroscopic data of the two main isomers do not fit with those of 20, and 
the structures of the products are not known so far.
6 ) The formation of 23 may be explained via the exchange of the THP protecting group 
for the (isobutyloxy)carbonyl group in the transformation of mandelic acid (1c) into 21 or 
an  incomplete  THP protecting  of  1c and  its  twofold  reaction  with  ClCO2iBu  and  N-
methylmorpholine (NMM, see below).
10
In a similar reaction as shown in  Scheme 6, the conversion of 2-hydroxyisobutyric 
acid (1a) into the O-protected monothiodiamide 25 was achieved in 92% yield (Scheme 7). In 
this case, the protection of the OH group and the activation of the carboxylic function of 1a 
occurred simultaneously by treatment  with ClCO2iBu and NMM. Deprotection of the OH 
group by treatment  with 0.8M NaOH in dioxane yielded  26 (85%), the precursor  for  the 
cyclization, whose structure was established by X-ray crystallography (Fig. 4).
Scheme 7
Fig. 4.  ORTEP Plot [18]  of the molecular structure of one of the three independent  
molecules of 26 (50% probability ellipsoids, arbitrary numbering of the atoms)
There are three symmetry-independent molecules of  26 in the asymmetric unit, but 
their conformations differ only very slightly, the main difference being in slightly different 
orientations of the Ph ring. In each molecule, the amide NH group forms an intramolecular H-
bond with the O-atom of the OH group, thereby creating a five-membered loop with a graph 
set motif of S(5). The OH group forms an intermolecular H-bond with the amide O-atom of a 
neighboring  symmetry-independent  molecule  and  thereby  links  the  three  independent 
molecules  into  infinite  one-dimensional  chains.  These  chains  run  parallel  to  the  [110] 
direction and are composed of repeating …A…B…C… units, which produce a tertiary graph set 
motif of C33(15).
The cyclization of 26 under the usual conditions of the ‘direct amide cyclization’, i.e., 
by bubbling dry HCl gas through a suspension of 26 in toluene at 100°, led also to a complex 
mixture  of  products,  and  chromatographic  workup  gave,  unexpectedly,  the  1,3-thiazole-
5(4H)-one 27 in 20% yield (Scheme 7). In addition, traces of 10a (Scheme 3) were detected, 
11
but  none  of  the  desired  3,3,6,6-tetramethyl-2-thioxomorpholin-5-one  of  type  20.  The 
formation of 27 may be rationalized by the cyclization of 26 to give the corresponding 1,3-
oxazol-5(4H)-thione and subsequent rearrangement to 27 as shown in Scheme 4.
With the aim of preparing thiomorpholine-2,5-dione 28 via acid-catalyzed cyclization 
of 29, 2-bromoisobutyric acid (30) was reacted with 2b leading to 31 in 97% yield (Scheme 
8). The exchange of bromide for the mercapto group was attempted by treatment of 31 with 
Na3PO3S according to the method described in [25]. Unfortunately, no 29 was obtained, and 
the only product, isolated in 28% yield as colorless plates, was 32. Most likely, it was formed 
from 31 by elimination of HBr.
Scheme 8
The structure of  32 was established by X-ray crystallography (Fig.  5a).  The space 
group is non-centrosymmetric, but achiral.  The NH group forms an intermolecular H-bond 
with the amide  O(5)-atom of  a  neighboring  molecule,  thereby linking  the  molecules  into 
infinite one-dimensional chains, which run parallel to the [001] direction and have a graph set 
motif of C(4).
Fig.  5.  ORTEP Plots [18]  of  the  molecular  structures  of  a)  32 and  b)  34 (50% 
probability ellipsoids, arbitrary numbering of the atoms)
Finally, the mercaptodiamide  29 was obtained in 95% yield from the reaction of 2-
mercaptoisobutyricacid  (33)  [25]  with  2b in  MeCN  at  room  temperature  (Scheme  8). 
Unfortunately, the transformation of the bromo compound 30 into the mercapto derivative 33 
was achieved in only 22% yield and was the yield-limiting step (see [25]). The cyclization of 
12
29 was attempted under the conditions of the ‘direct amide cyclization’, i.e., a stream of dry 
HCl gas was bubbled through a suspension of 29 in toluene at 100° for 15 min. After usual 
workup,  the  crude  solid  product,  which  was  believed  to  be  28,  was  purified  by 
chromatography to give the mercapto acid 34 in 60% yield (Scheme 8). 
The  unexpected  structure  of  the  product  was  again  established  by  X-ray 
crystallography (Fig. 5b). The carboxylic OH group forms an intermolecular H-bond with the 
amide O(3)-atom of a neighboring molecule. This interaction links pairs of molecules across a 
centre of inversion into dimers, which have a graph set motif of R22(7). The SH group forms 
an intermolecular H-bond with the carbonyl  O(6)-atom of the carboxyl  group of the same 
neighboring molecule and so forms a second set of links between the H-bonded dimers. This 
latter interaction has a graph set motif of R22(8). The amide NH group does not partake in any 
H-bonding interactions.
The formation of 34, which is the product of the hydrolysis of the terminal amid group 
of 29, may be explained  via the acid-catalyzed intramolecular condensation to give the 1,3-
oxazol-5(4H)-one  35 (Scheme  8)  and  subsequent  hydrolytic  ring  opening.  This  reaction 
sequence, i.e., the selective cleavage of the terminal amide group in Aib peptides, is generally 
observed by treatment of peptides of type 29 with acids in aqueous media [17][26]. It is the 
basis of the ‘azirine/oxazolone method’ in peptide synthesis. On the other and, it has been 
shown that under anhydrous conditions the formed 1,3-oxazol-5(4H)-ones are stable and can 
be isolated [27]. Therefore, it may be assumed that  34 is the product of the hydrolytic ring 
opening of the desired thiomorpholine-2,5-dione  28, which,  in analogy to the synthesis  of 
morpholine-2,5-diones 4 (Scheme 2), is formed from 29 → 35 → 28 (Scheme 8).
In  conclusion,  a  convenient  synthesis  of  3,3-dimethylmorpholine-2,5-diones  was 
elaborated by using a combination of the ‘azirine/oxazolone method’ and the ‘direct amide 
13
cyclization’. The corresponding 5-monothioxo and 2,5-dithioxo derivatives are accessible via 
stepwise  thionation  with  Lawesson reagent.  On the  other  hand,  attempted  cyclizations  of 
sulfur-containing  linear  precursors  were  not  successful  and  led  to  mixtures  of  products. 
Whereas 1,3-oxazol-5(4H)-ones of type  A (Scheme 2) under acidic conditions are prone to 
undergo the ring enlargement to give 3,3-dimethylmorpholine-2,5-diones 4, the corresponding 
1,3-thiazole-5(4H)-ones of type  27 (Scheme 7) are stable under the conditions of the ‘direct 
amide cyclization’ and do not show any tendency for a ring enlargement reaction.
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Experimental Part
1.  General. Solvents were purified by standard procedures. TLC: aluminium sheets, 
silica gel 60 F254 (Merck). Prep. TLC: glass plates, silica gel 60 F254 (2 mm; Merck). Column 
chromatography (CC): silica gel C-560 (0.04–0.063 mm; Uetikon-Chemie). Medium pressure 
liquid chromatography (MPLC): LiChroprep Si 60, 15–25  µm (Merck); column:  Kron-Lab 
4/98-Pro, 480  × 30 mm or  Labomatic, 380  × 20 mm. M.p.:  Mettler-FP-5 or  Büchi B-450 
apparatus; uncorrected.  IR Spectra: Perkin-Elmer-781 or Perkin-Elmer Spectrum one FT-IR 
spectrophotometer; in KBr unless otherwise stated.  1H- and 13C-NMR Spectra:  Bruker-AC-
300 or Bruker-ARX-300 instrument (300 and 75.5 MHz, resp.), in CDCl3; multiplicity of C-
atoms from DEPT spectra. MS: Finnigan MAT-90, Finnigan SSQ-700 (EI, CI), or Finnigan 
TSQ-700 instrument  (ESI).  Elemental  analyses  were  performed  by  the  Mikroanalytisches 
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Laboratorium des Organisch-chemischen Instituts  der Universität  Zürich (Elementar Vario 
EL instrument). 
General Procedure 1 (GP 1).  Coupling of 2H-Azirin-3-amines with Carboxylic and 
Thiocarboxylic Acids. To a stirred soln. of the acid in MeCN at 0°, 2,2,N-trimethyl-N-phenyl-
2H-azirin-3-amine (2b) was added drop wise. The mixture was stirred at r.t. for 2 – 22 h, and 
then diluted with Et2O. The precipitate was filtered off and purified by chromatography or 
recrystallization.
General Procedure 2 (GP 2).  Direct  Amide Cyclization.  A stirred suspension of a 
dipeptide in dry toluene was heated up to 90–100° under N2. A strong stream of dry HCl-gas 
was bubbled through the soln. for 10–30 min at the chosen temperature. The resulting soln. 
was purged with N2 for 30 min to remove remaining HCl, the toluene was evaporated, and 10 
ml  of  THF/Et2O  (1:1)  were  added  to  the  residue.  After  30  min  of  stirring  at  r.t.,  the 
precipitated  Ph(Me)NH.HCl  was  removed  by  filtration,  followed  by  evaporation  of  the 
solvent, yielding a solid crude product, which was purified by chromatography.
General procedure 3 (GP 3). Monothionation with Lawesson Reagent (L.R.). A stirred 
suspension of 1 equiv. of a morpholine-2,5-dione 4 and 0.5 equiv. of L.R. in dry toluene was 
heated to 90–100° until a clear soln. was obtained. Then, the soln. was heated to reflux for 30 
min. By cooling the mixture to r.t., remaining L.R. precipitated and was removed by filtration. 
After evaporation of the toluene, the residue was purified by CC. 
General procedure 4 (GP 4).  Dithionation with  Lawesson  Reagent (L.R.). A stirred 
suspension of 1 equiv. of a 5-thioxomorpholin-2-one 10 and 2.5 equiv. of L.R. in dry toluene 
was heated to reflux for 2–6 d. By cooling the mixture to r.t., remaining L.R. precipitated and 
was removed by filtration. After evaporation of the toluene, the residue was purified by CC. 
2. Starting materials. 2,2,N-Trimethyl-N-phenyl-2H-azirin-3-amine (2b) was prepared 
according to [28]. All other chemicals were commercially available.
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3.  Azirine-Coupling  with  2-Hydroxyacids.  3.1. Synthesis  of  2-(2-Hydroxy-2-
methylpropionamido)-N-phenyl-N,2-dimethylpropionamide (3aa).  According to GP 1: 270.7 
mg  (4.8 mmol) of 2-hydroxyisobutyric acid (1a) in MeCN (20 ml), 836.5 mg (4.8 mmol) of 
2b, stirred for 2 h at r.t. The product was purified by CC (SiO2, CH2Cl2/MeOH 20:1) and 
recrystallized from MeCN. Yield: 1.2 g (95%) of 3aa.  Colorless needles. M.p. 131–134°. IR: 
3359s, 3059w, 3009w, 2992m, 2974m, 2930s, 1637vs, 1595s, 1525s, 1498s, 1463m, 1454m, 
1399s, 1367s, 1357s, 1262m, 1226m, 1196s, 1180m, 1161w, 1126s, 1089s, 1070m, 1025w, 
992m, 966m, 773m, 709s, 641m, 616m. 1H-NMR: 7.40–7.24 (m, 5 arom. H); 7.15 (br. s, NH); 
3.28 (s, MeN); 1.47, 1.35 (2s, 2 Me2C). 13C-NMR: 175.2, 173.4 (2s, 2 CO); 144.7 (s, arom. 
C); 129.4, 128.2, 127.9 (3d, 5 arom. CH); 73.2, 57.9 (2s, 2 Me2C); 41.4 (q, MeN); 27.4, 26.1 
(2q, 2  Me2C). ESI-MS: 579 (8, [2M+Na]+), 301 (100, [M+Na]+). Anal. calc. for C15H22NO3 
(278.40): C 64.73, H 7.97, N 10.10; found: C 64.83, H 8.10, N 10.37.
Recrystallization from MeCN by slow evaporation of the solvent yielded colorless 
needles suitable for the X-ray crystal structure determination.
3.2. Synthesis  of  2-(2-Hydroxy-3-phenylpropionamido)-N-phenyl-N,2-dimethyl-
propionamide (3ab). According to GP 1: 408 mg  (2.5 mmol) of DL-phenyllactic acid (1b) in 
MeCN (20 ml),  472 mg (2.7 mmol)  of  2b,  stirred for 22 h at  r.t.  Purified by CC (SiO2, 
CH2Cl2/Et2O 6:1). Yield: 773 mg (92%) of 3ab. Colorless needles. M.p. 127–128°. IR: 3440s, 
3324s, 2985w, 2932w, 1640vs, 1593m, 1527s, 1494v, 1454m, 1394s, 1374m, 1285m, 1262w, 
1206m, 1093s, 740w, 709s, 630w.  1H-NMR: 7.43–7.14 (m, 10 arom. H); 6.46 (br.  s, NH); 
3.98–3.89 (m, PhCH2CH); 3.25 (s, MeN); 3.05, 2.81 (AB-like, PhCH2CH); 2.13 (d,  J = 5, 
OH); 1.442, 1.439 (2s, Me2C). 1H-NMR (CD3OD): 7.42–7.15 (m, 10 arom. H); 4.00–3.80 (m, 
PhCH2CH);  3.21  (s,  MeN);  3.03–2.75  (AB of  ABX,  JAB =  13.8,  JAX =  7.7,  JBX =  4.0, 
PhCH2CH); 1.39, 1.38 (2s, Me2C).  13C-NMR: 172.8, 171.2 (2s, 2 CO); 144.8, 136.7 (2s, 2 
arom. C); 129.5, 129.3, 128.4, 127.7, 126.8 (5d, 10 arom. CH); 72.9 (d, PhCH2CH); 57.6 (s, 
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Me2C); 40.3 (t, PhCH2); 41.3 (q, MeN); 26.9, 26.1 (2q, Me2C). 13C-NMR (CD3OD): 174.9 (s, 
2 CO); 146.2, 138.9 (2s, 2 arom. C); 130.8, 130.4, 129.0, 128.8, 128.5, 127.3 (6d, 10 arom. 
CH); 73.6 (d, PhCH2CH); 58.2 (s, Me2C); 41.5 (t, PhCH2); 41.3 (q, MeN); 27.0, 26.7 (2q, 
Me2C). ESI-MS: 703 (20, [2M+Na]+), 363 (12, [M+Na]+), 341 (40, [M+H]+), 234 (100). 
3.3. Synthesis  of  2-(2-Hydroxy-2-phenylacetamido)-N-phenyl-N,2-dimethylpropion-
amide (3ac).  According to GP 1: 152 mg  (1 mmol) of  DL-mandelic acid (1c) in MeCN (6 
ml), 192 mg (1.1 mmol) of 2b in MeCN (8 ml), stirred for 3 h at r.t. Yield: 310 mg (95%) of 
3ac. Colorless needles. M.p. 149–150°. IR: 3340vs, 3060w, 3030w, 3010w, 2981w, 2914w, 
1645vs,  1594m,  1520vs,  1492vs,  1455m,  1392s,  1373m,  1362m,  1373w,  1362m,  1327m, 
1268m, 1227m, 1204w, 1190w, 1090s, 1066m, 744w, 710s, 697m. 1H-NMR (CD3OD): 7.42–
7.20 (m,  10  arom.  H);  4.18  (s,  PhCH);  3.15  (s,  MeN);  1.47,  1.45  (2s,  Me2C).  13C-NMR 
(CD3OD): 175.0, 174.0 (2s, 2 CO); 145.4, 141.5 (2s, 2 arom. C); 130.4, 129.3, 129.0, 128.8, 
128.5, 127.9 (6d, 10 arom. CH); 75.1 (s, PhCH); 58.3 (s, Me2C); 41.2 (q, MeN); 26.8, 26.6 
(2q, Me2C). 
4.  Direct  Amide  Cyclization.  4.1. Synthesis  of  3,3,6,6-Tetramethylmorpholine-2,5-
dione (4aa) [1b]. According to GP 2: 500 mg (1.8 mmol) of 3aa in dry toluene (100 ml), 90°, 
HCl  gas  for  30  min.  The  product  was  purified  by  CC  (SiO2,  CH2Cl2/Et2O  2:1)  and 
recrystallized from toluene. Yield of 4aa: 187 mg (61%). Colorless crystals. M.p. 139–140°. 
IR:  3354s,  3202w,  3073w,  2987m,  2932m,  1743vs,  1677s,  1643s,  1528m,  1472s,  1444s, 
1385w, 1369m, 1326s, 1228s, 1201m, 1154vs, 988m, 859m, 692w. 1H-NMR: 6.82 (br. s, NH); 
1.75, 1.70 (2s, 2 Me2C).  13C-NMR: 170.2, 169.8 (2s, 2 CO); 82.9 (s, C(6)); 56.3 (s, C(3)); 
29.4,  27.0  (2q,  2  Me2C).  CI-MS  (NH3):  172  (100,  [M+H]+).  Anal.  calc.  for  C8H13NO3 
(171.20): C 56.13, H 7.65, N 8.18; found: C 55.91, H 7.57, N 8.23.
Recrystallization from toluene by slow evaporation of the solvent yielded colorless 
needles suitable for the X-ray crystal structure determination.
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4.2. Synthesis  of  6-Benzyl-3,3-dimethylmorpholine-2,5-dione (4ab)  [1b][21]. 
According to GP 2: 2.19 g (6.44 mmol) of 3ab in dry toluene (300 ml), 100°, HCl gas for 15 
min. The product was purified by CC (SiO2, CH2Cl2/Et2O 6:1) and recrystallized from Et2O. 
Yield of  4ab: 407 mg (27%). Colorless needles. M.p. 164–165°. IR: 3190s, 3066s, 2920s, 
1746vs, 1686vs, 1498s, 1429vs, 1388s, 1360s, 1340s, 1283vs, 1204s, 1160vs, 1072vs, 1045s, 
1004s, 932w, 908w, 820m, 767m, 740vs, 693vs.  1H-NMR: 7.34–7.24 (m, 5 arom. H); 5.13 
(dd,  J =  5.2,  4.5,  PhCH2CH);  3.37–3.24  (AB of  ABX,  JAB =  14.4,  JAX =  5.2,  JBX =  4.5, 
PhCH2CH); 1.49, 1.02 (2s, Me2C).  13C-NMR: 169.5, 166.2 (2s, 2 CO); 134.7 (s, arom. C); 
130.4, 128.7, 127.4 (3d, 5 arom. CH); 79.2 (d, C(6)); 55.5 (s, C(3)); 29.0, 27.9 (2q,  Me2C). 
CI-MS (NH3): 252 (14), 251 (100, [M+NH4]+), 234 (15, [M+H]+).
4.3. Synthesis of 6-Phenyl-3,3-dimethylmorpholine-2,5-dione (4ac) [1b]. According to 
GP 2: 326 mg (1 mmol) of 3ac in dry toluene (50 ml), 100°, HCl gas for 10 min. The product 
was recrystallized from Et2O/pentane 1:2. Yield of 4ac: 48 mg (22%). Colorless needles. M.p. 
197–198°. IR: 3187s, 3083s, 3001s, 2975s, 2929s, 1747vs, 1682vs, 1607vs, 1501s, 1458vs, 
1441vs,  1415vs,  1388s,  1372s,  1355m,  1316vs,  1301vs,  1284vs,  1211m,  1163vs,  1079m, 
1042vs, 1011s, 931m, 911m, 859s, 806vs, 752vs, 697vs. 1H-NMR: 7.43–7.30 (m, 5 arom. H); 
5.84 (s, PhCH); 1.54, 1.30 (2s, Me2C). 13C-NMR: 169.1, 165.3 (2s, 2 CO); 133.3 (s, arom. C); 
128.2, 127.9, 125.2 (3d, 5 arom. CH); 78.9 (d, C(6)); 54.5 (s, C(3)); 27.6, 27.3 (2q, Me2C). 
5.  Thionation  with  Lawesson Reagent.  5.1. Synthesis  of  3,3,6,6-Tetramethyl-5-
thioxomorpholin-2-one (10a).  According to  GP 3: 150 mg (0.876 mmol)  of  4aa,  177 mg 
(0.438 mmol) of Lawesson reagent (L.R.), dry toluene (10 ml), 90°, 30 min. Purification by 
CC (SiO2, CH2Cl2/Et2O 2:1). Yield of 10a: 164 mg (95%). Colorless crystals. M.p. 174–175°. 
IR: 3166m,  3041m,  3005m,  2996m,  2977m,  1738vs,  1557s,  1462s,  1440m,  1421s,  1378w, 
1365m, 1329s, 1204m, 1184m, 1143m, 1051s, 982s, 966m, 826m, 668m, 658w. 1H-NMR: 8.15 
(br. s, NH); 1.84, 1.65 (2s, 2 Me2C). 13C-NMR: 200.5 (s, C(5)); 169.4 (s, C(2)); 82.8 (s, C(6)); 
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56.4  (s,  C(3));  29.3,  27.0  (2s,  2  Me2C).  CI-MS:  188  (100,  [M+H]+).  Anal.  calc.  for 
C8H13NO2S: (187.26): C 51.31, H 6.99, N 7.48, S 17.12; found: C 51.38, H 6.47, N 7.31, S 
17.24.
Recrystallization from toluene by slow evaporation of the solvent yielded colorless 
prisms suitable for the X-ray crystal structure determination. A second recrystallization, also 
from toluene, yielded  crystals of a second polymorph.
5.2. Synthesis  of  6-Benzyl-3,3-dimethyl-5-thioxomorpholin-2-one (10b)  [21]. 
According to GP 3: 276 mg (1.19 mmol) of 4ab, 240 mg  (0.59 mmol) of L.R., dry toluene 
(15 ml),  100°, 30 min. Purification by CC (SiO2, CH2Cl2/pentane 3:2), recrystallized from 
CH2Cl2/Et2O. Yield of  10b: 281 mg (96%). Colorless needles. M.p. 174–175°. IR: 3286vs, 
3067m,  3033m,  3002m,  2956w,  1749vs,  1552vs,  1497m,  1469s,  1454s,  1437m,  1414s, 
1386vs,  1373m,  1279vs,  1170vs,  1103s,  1074s,  1028s,  1009vs,  972w,  953w,  893m,  785m, 
761s. 1H-NMR: 7.35–7.24 (m, 5 arom. H); 5.55 (t-like, J = 4.7, PhCH2CH); 3.65–3.48 (AB of 
ABX, JAB = 14.2, JAX = 4.7, JBX = 4.6, PhCH2CH); 1.58, 0.81 (2s, Me2C). 13C-NMR: 193.7 (s, 
C(5)); 168.3 (s, C(2)); 134.2 (s, 1 arom. C); 130.8, 128.8, 127.8 (3d, 5 arom. CH); 85.5 (d, 
C(6)); 57.3 (s, C(3)); 41.7 (t, PhCH2); 28.8, 27.0 (2s, Me2C). EI-MS: 250 (14), 249 (100, M+), 
205 (15), 147 (11), 130 (23), 115 (26), 91 (51). Anal. calc. for C13H15NO2S: (249.33): C 62.62, 
H 6.06, N 5.62, S 12.86; found: C 62.51, H 6.13, N 5.56, S 12.70.
5.3. Synthesis of 6-Phenyl-3,3-dimethyl-5-thioxomorpholin-2-one (10c).  According to 
GP 3: 90 mg (0.4 mmol) of 4ac, 80 mg  (0.2 mmol) of L.R., dry toluene (5 ml), 90–100°, 20 
min. Purification by prep. TLC (SiO2, CH2Cl2/pentane 3:2), recrystallized from toluene. Yield 
of  10c: 66 mg (68%). Colorless needles. M.p. 198–199°. IR: 3149s, 3027s, 2918s, 1742vs, 
1548vs, 1499m, 1462vs, 1411vs, 1366m, 1327vs, 1305s, 1267s, 1204s, 1178s, 1119s, 1078m, 
1010vs,  912m,  828m,  780m,  743vs,  695vs,  656s.  1H-NMR ((D6)DMSO): 7.45–7.38 (m,  5 
arom. H); 4.58 (s, PhCH); 1.58, 1.43 (2s, Me2C).  13C-NMR ((D6)DMSO): 192.7 (s, C(5)); 
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169.7 (s, C(2)); 137.1 (s, 1 arom. C); 128.7, 128.2, 127.8 (3d, 5 arom. CH); 84.7 (d, C(6)); 
56.3 (s, C(3)); 26.5, 26.3 (2s, Me2C). EI-MS: 236 (14), 235 (100, M+), 134 (34), 107 (42), 105 
(10), 101 (11), 100 (37), 86 (16), 84 (26), 77 (19). 
5.4. Synthesis of 3,3,6,6-Tetramethylmorpholine-2,5-dithione (11a).  According to GP 
4: 100 mg (0.53 mmol) of 10a, 539 mg (1.34 mmol) of L.R., dry toluene (7 ml), reflux for 6d. 
Purification  by  CC  and  prep.  TLC  (SiO2,  hexane/AcOEt  1:1),  recrystallized  from 
hexane/AcOEt 1:1. Yield of 11a: 49 mg (49%). Yellow crystals. M.p. 156–158°. IR: 3248m, 
3165s, 3046m, 2974m, 2928m, 1742w, 1560vs, 1528m, 1465s, 1418s, 1361m, 1318vs, 1279s, 
1185m, 1142m, 1109vs, 1044s, 967m, 907m, 819m, 762m, 654m, 599m. 1H-NMR: 8.65 (br. s, 
NH); 1.82, 1.72 (2s, 2 Me2C). 13C-NMR: 216.8 (s, C(2)); 199.9 (s, C(5)); 91.4 (s, C(6)); 64.9 
(s, C(3)); 32.9, 30.0 (2s, 2 Me2C). EI-MS: 203 (7, M+), 175 (21), 143 (58), 110 (9), 100 (11), 
86 (100), 85 (21), 75 (21). Anal. calc. for C8H13NOS2: (203.33): C 47.26, H 6.44, N 6.89, S 
31.54; found: C 47.14, H 6.46, N 6.61, S 31.30.
Recrystallization from toluene by slow evaporation of the solvent yielded colorless 
prisms suitable for the X-ray crystal structure determination.
5.5. Synthesis of 6-Benzyl-3,3-dimethylmorpholine-2,5-dithione (11b) [21]. According 
to GP 4: 95 mg (0.38 mmol) of 10b, 384 mg  (0.95 mmol) of L.R., dry toluene (10 ml), reflux 
for 2 d. Purification by prep. TLC (SiO2, CH2Cl2/hexane 1:1). Yield of  11b: 28 mg (28%). 
Yellow  solid.  M.p.  123–124°.  IR:  3151m,  3031s,  2945s,  1752w,  1656w,  1570s,  1496m, 
1467m, 1454m, 1435m, 1385s, 1351m, 1246s, 1215s, 1177s, 1152s, 1131s, 1093m, 1070m, 
1035m, 1014m, 973s, 947s, 908m, 703s. 1H-NMR: 8.61 (br. s, NH); 7.37–7.23 (m, 5 arom. H); 
5.52 (dd,  J = 5.6, 4.4, PhCH2CH); 3.72–3.54 (AB of  ABX,  JAB = 14.4,  JAX = 5.6,  JBX = 4.4, 
PhCH2); 1.65, 1.16 (2s, Me2C). 13C-NMR: 215.2 (s, C(2)); 193.3 (s, C(5)); 134.4 (s, 1 arom. 
C); 130.8, 128.7, 127.6 (3d, 5 arom. CH); 87.2 (d, C(6)); 64.3 (s, C(3)); 41.2 (t, PhCH2); 32.4, 
31.6 (2s, Me2C). EI-MS: 265 (4, M+), 205 (21), 147 (20), 115 (39), 91 (51), 65 (14), 58 (100). 
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CI-MS (NH3): 266 (100, [M+H]+), 234 (14), 232 (12), 208 (23), 206 (45).  Anal.  calc.  for 
C13H15NOS2: (265.39): C 58.83, H 5.69, N 5.28, S 24.16; found: C 58.71, H 5.45, N 5.03, S 
24.02.
6.  Synthesis  of  Monothiodiamides  and Attempted  Acid-Catalyzed  Cyclizations.  6.1. 
Synthesis  of  N-[1-Methyl-1-(N-methyl-N-phenylthiocarbamoyl)ethyl]-O-(tetrahydropyran-2-
yl)mandelamid (22). To a suspension of DL-mandelic acid (1c, 304 mg, 2 mmol) in dry MeCN 
(5 ml) at 0° were added 3,4-dihydropyrane (195 mg, 2.3 mmol) and 0.04 ml of a 2M aq. HCl. 
The mixture was stirred for 3 h at r.t., the solvent evaporated, and the residue dried in vacuo 
to give crude THP-protected mandelic acid as a mixture of two diastereoisomers.  1H-NMR: 
7.51–7.30 (m, 5 arom. H); 5.23, 5.21 (2s, PhCH); 4.91, 4.58 (2t, CH of THP); 3.98–3.43 (2m, 
1 CH2 of THP); 1.90–1.26 (m, 3 CH2 of THP). 13C-NMR: 176.8, 175.6 (2s, CO); 136.2, 135.6 
(2s, 1 arom. C); 128.73, 128.68, 128.6, 127.6, 127.3, 126.6 (6d, 5 arom. CH); 97.5, 97.1 (2d, 
CH of THP); 75.5, 72.5 (2d, PhCH); 63.0, 62.1 (2t, CH2 of THP); 30.3, 30.1, 25.2, 25.1, 19.3, 
18.7 (6t, 3 CH2 of THP).
The crude protected mandelic acid was dissolved in abs. THF (5 ml), the soln. cooled 
to ca. –10°, and N-methylmorpholine (NMM, 405 mg, 4 mmol) and isobutyl chloroformiate 
(ClCO2iBu, 273 mg, 2 mmol) were added. After 5 min, freshly prepared H2S (from Na2S.H2O 
and 50proz. H2SO4) was bubbled through the mixture, which was stirred for 1 h at –10°. Then, 
Et2O was added, the mixture washed with 0.1M aq. H3PO4, the org. phase dried (Na2SO4), the 
solvents evaporated, and the residue dried i.HV. The crude THP-protected mandelic thioacid 
(21) was dissolved in CH2Cl2, the soln. cooled to 0°, 2b (348 mg, 2 mmol) slowly added, and 
the mixture stirred at r.t. for 15 h. Then, the mixture was extracted with 5proz. aq. NaHSO4 
(3×), the aq. phases whased with CH2Cl2, and the combined org. phases dried (Na2SO4). The 
solvent was evaporated and chromatographic workup (CC, SiO2, CH2Cl2/Et2O 20:1) gave two 
fractions, which were crystallized.
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Data of 22. Yield: 443 mg (52%). M.p. 109–110° (Et2O/pentane). Colorless crystals. 
IR: 3414w, 3248s, 2940s, 2871w, 1666vs, 1491vs, 1463vs, 1367vs, 1259m, 1238m, 1204s, 
1184m,  1119vs,  1101vs,  1077s,  1037s,  967s,  909m,  777m,  708vs.  1H-NMR  (2 
diastereoisomers): 8.74, 8.67 (2 br. s, NH); 7.48–7.10 (m, 10 arom. H); 5.02, 4.98 (2s, PhCH); 
4.85, 4.54 (2t,  J = 3, CH of THP); 4.00–3.80, 3.60–3.40 (2m, CH2 of THP); 3.70 (s, MeN); 
2.09–1.26  (m,  3  CH2 of  THP);  1.62,  1.57,  1.54,  1.43  (4s,  Me2C).  13C-NMR  (2 
diastereoisomers): 209.3 (s, CS); 169.4, 168.8 (2s, CO); 147.1, 138.5, 137.4 (3s, 2 arom. C); 
129.5, 128.2, 127.84, 127.78, 127.0, 126.8 (6d, 10 arom. CH); 98.2, 95.3 (2d, CH of THP); 
78.9, 77.5 (2d,  PhCH); 62.82, 62.80 (2s,  Me2C);  62.1,  62.0 (2t,  1 CH2 of THP); 51.4 (q, 
MeN); 30.5, 30.3 (2t, 1 CH2 of THP); 28.1, 28.0, 27.9, 27.8 (4q, Me2C); 25.4, 25.3 (2t, 1 CH2 
of THP); 18.9, 18.8 (2t, 1 CH2 of THP). ESI-MS (CH2Cl2 + Na): 449 (12, [M+Na]+), 427 (40, 
[M+H]+), 343 (53, [M–Ph(Me)N+Na]+), 175 (100).
O-[(Isobutyloxy)carbonyl]-N-[1-methyl-1-(N-methyl-N-phenylthiocarbamoyl)ethyl]-
mandelamid (23). Yield: 167 mg (20%). Colorless crystals. 1H-NMR: 7.66 (br. s, NH); 7.44–
7.20 (m, 10 arom. H); 5.68 (s, PhCH); 4.00–3.85 (m, CH2); 3.71 (s, MeN); 2.53–1.85 (m, 
Me2CH); 1.65, 1.60 (2s, Me2C); 0.96, 0.95 (2d,  J = 6.7,  Me2CH).  13C-NMR: 208.3 (s, CS); 
165.9, 153.5 (2s, 2 CO); 147.5, 135.5 (2s, 2 arom. C); 129.6, 129.0, 128.7, 128.4, 127.5, 126.3 
(6d, 10 arom. CH); 78.7 (d, PhCH); 74.7 (t, CH2); 63.0 (s, Me2C); 51.4 (q, MeN); 29.1 (q, 
Me2C); 27.8 (d, Me2CH); 19.0, 18.9 (2q, Me2CH). CI-MS: 444 (22), 443 (100, [M+H]+), 269 
(16), 192 (27). Anal. calc. for C24H30N2O4S (442.58): C 65.13, H 6.83, N 6.33, S 7.24; found: 
C 65.00, H 6.71, N 6.25, S 7.42.
Suitable  crystals  for  the  X-ray  crystal-structure  determination  were  obtained  from 
hexane by slow evaporation of the solvent.
6.2.  Synthesis of  N-[1-Methyl-1-(N-methyl-N-phenylthiocarbamoyl)ethyl]mandelamid 
(24). A mixture of  22 (427 mg, 1 mmol) and pyridinium  para-toluenesulfonate (PPTS, 30 
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mg) in EtOH (20 ml) was heated under reflux for 15 h. Then, the solvent was evaporated and 
the residue purified by CC (SiO2, CH2Cl2/Et2O 20:1) and recrystallization from AcOEt/hexane 
1:1,  yielding  348 mg  (quant.)  of  24.  M.p.  145–146°.  Colorless  solid.  IR:  3324s,  3060m, 
3004m,  2983m,  2982m,  1692s,  1673vs,  1652vs,  1592m,  1515vs,  1490vs,  1465vs,  1451vs, 
1431s,  1370vs,  1359vs,  1256m,  1215s,  1182m,  1163m,  1101vs,  1068s,  1027m,  1017m, 
1003m, 992m, 777s, 729m, 707s. 1H-NMR: 7.46–7.18 (m, 10 arom. H); 4.68 (s, PhCH); 3.96 
(s, MeN); 1.60, 1.52 (2s, Me2C). 13C-NMR: 208.2 (s, CS); 170.3 (s, CO); 147.6, 139.3 (2s, 2 
arom. C); 129.6, 128.7, 128.5, 128.4, 126.7, 126.3 (6d, 10 arom. CH); 74.2 (d, PhCH); 62.9 
(s, Me2C); 51.3 (q, MeN); 29.3, 29.2 (2q, Me2C).
6.3.  Attempted Cyclization of 24.  Through a soln. of  24 (342 mg, 1 mmol) in abs. 
toluene (130 ml) at 100–110°, dry HCl gas was bubbled for 20 min. Then, the solvent was 
evaporated,  the  residue  dissolved  in  THF/Et2O and  the  mixture  stirred  for  30  min.  The 
precipitate  (Ph(Me)NH.HCl)  was  filtered  of  and  the  solvent  evaporated.  Chromatographic 
workup of the residue gave 33% of the starting material  24 and three fractions of impure 
isomeric  compounds  with  the  mass  of  the  expected  3,3-dimethyl-6-phenyl-2-
thioxomorpholin-5-one (20, ESI-MS (CH2Cl2+Na): 236 ([M+1]+) in ca. 26, 12, and 6% yield, 
respectively.
6.4.  Synthesis  of  2-{[(Isobutyloxy)carbonyl]oxy}-2-methyl-N-[1-methyl-1-(N-methyl-
N-phenylthiocarbamoyl)ethyl]propionamide (25). To a soln. of 2-hydroxyisobutyric acid (1a, 
500 mg, 4.8 mmol) in dry THF (30 ml), NMM (2.43 g, 24 mmol) and ClCO2iBu (1.6 g, 12 
mmol) were added at –10°. Immediately a white solid precipitated. The mixture was stirred 
for ca. 5 min, then a slow stream of H2S was bubbled through the soln. for 2.5 h. The mixture 
was diluted with Et2O, and extracted with 0.1M aq. H3PO4 (2×). The combined org. phase was 
dried (MgSO4), the solvent evaporated, and the residue dried i.HV. The formed crude thioacid 
was dissolved in abs. MeCN and cooled to 0°, and 2b (835 mg, 4.8 mmol) was added slowly. 
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The  mixture  was  allowed  to  reach  r.t.  and  was  stirred  until  the  starting  material  was 
completely consumed (TLC, 24 h). Then, the solvent was evaporated and the residue dried 
i.HV. Purification by CC (SiO2, AcOEt/hexane 1:2) gave 1.68 g (92%) of 25. 1H-NMR:  8.33 
(br. s, NH); 7.38–7.16 (m, 5 arom. H); 3.82 (d, J = 6.8, CH2); 3.66 (s, MeN); 3.65–1.87 (m, 
Me2CH); 1.55, 1.46 (2s, 2 Me2C); 0.90–0.88 (m,  Me2CH).  13C-NMR: 209.1 (s, CS); 170.2, 
153.0 (2s, 2 CO); 147.2 (s, arom. C); 129.5, 128.4, 126.8 (3d, 5 arom. CH); 82.7, 62.6 (2s, 2 
Me2C); 51.4 (MeN); 27.7, 24.0 (2q, 2  Me2C); 27.1 (d, Me2CH); 18.9 (q,  Me2CH). ESI-MS: 
417 (100, [M+Na]+). Anal. calc. for C20H30NO4S: (380.52): C 60.89, H 7.66, N 7.10, S 8.13; 
found: C 60.73, H 7.50, N 7.28, S 7.99.
6.5.  Synthesis  of  2-Hydroxy-2-methyl-N-[1-methyl-1-(N-methyl-N-phenylthio-
carbamoyl)ethyl]propionamide (26).  A soln.  of  25 (982 mg,  2.58 mmol)  in  a  mixture  of 
dioxane (14.7 ml) and 0.8M NaOH (14.7 ml) was stirred at r.t. for 30 min. After neutralizing 
by treatment with Dowex-50 (pyridinium form), the soln. was diluted with H2O and extracted 
with CH2Cl2 (2×). The org. soln. was dried (Na2SO4), the solvent evaporated, and the residue 
was purified by CC (SiO2) and crystallized from hexane/AcOEt (2:1): 646 mg (85%) of 26. 
M.p. 112–114°. Colorless crystals. IR: 3314s, 3006w, 2982s, 2930m, 1642vs, 1593m, 1492s, 
1359m, 1262m, 1161m, 1135m, 1099s, 1012w, 1003m, 992w, 962m, 917m, 889w, 796w, 775s, 
766m, 704vs, 671vs. 1H-NMR: 7.45 (s, NH); 7.45–7.25 (m, 5 arom. H); 3.74 (s, MeN); 1.59, 
1.37 (2s, 2 Me2C). 13C-NMR: 209.0 (s, CS); 174.6 (s, CO); 144.4 (s, arom. C); 129.4, 128.3, 
126.5 (3d, 5 arom. CH); 73.14, 62.52 (2s, 2 Me2C); 52.0 (q, MeN); 29.0, 27.2 (2q, 2 Me2C). 
CI-MS: 297 (6), 296 (18), 295 (100, [M+1]+), 228 (10), 192 (35), 121 (12). Anal. calc. for 
C15H22N2O2S (294.41): C 61.19, H 7.53, N 9.51, S 10.89; found: C 61.01, H 7.42, N 9.33, S 
10.81.
Suitable  crystals  for  the  X-ray  crystal-structure  determination  were  obtained  from 
hexane/AcOEt by slow evaporation of the solvent.
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6.6. Cyclization of 26. According to GP 2, a soln. of 26 (284 mg, 0.97 mmol) in abs. 
toluene (50 ml) at 100° under N2 was treated with dry HCl-gas for 25 min. Usual workup and 
purification by prep. TLC (SiO2,  CH2Cl2/Et2O 2:1) gave 50 mg (20%) of  2-(1-hydroxy-1-
methylethyl)-4,4-dimethyl-1,3-thiazol-5(4H)-one (27) as a yellow oil and traces of a product, 
which  was  proposed  to  be  the  expected  3,3,6,6-tetramethyl-2-thioxomorpholin-5-one. 
Treatment of 27 with toluene led to a colorless solid. IR: 3387s (br), 2980m, 2934m, 2874w, 
1721vs,  1659vs,  1514s,  1460m,  1365m,  1227m,  1193m,  967m,  919w,  848w,  827m,  810m, 
768w. 651m, 621m. 1H-NMR: 3.56 (br. s, OH); 1.51, 1.41 (2s, 2 Me2C). 13C-NMR: 211.3 (s, 
CO); 172.4 (s, C=N); 83.1 (s, C(4)); 67.3 (s, Me2C); 28.4, 24.3 (2q, 2 Me2C). Anal. calc. for 
C8H13NO2S: (187.26): C 15.31, H 7.00, N 7.48, S 17.12; found: C 15.07, H 7.22, N 7.29, S 
17.34.
7.  Attempted  Synthesis  of  3,3,6,6-Tetramethylthiomorpholine-2,5-dione (28).  7.1. 
Synthesis  of  2-Bromo-2-methyl-N-[1-methyl-1-(N-methyl-N-phenylcarbamoyl)ethyl]-
propionamide (31). According to GP 1: 802 mg (4.8 mmol) of 2-bromo-2-methylpropionic 
acid (30) in MeCN (35 ml), 836 mg (4.8 mmol) of 2b, 2.5 h at r.t. Purification by CC (SiO2, 
CH2Cl2/MeOH 10:1) and dried i.HV. Yield: 1.6 g (97%) of 31. M.p. 135.4–136.2°. Colorless 
crystals.  IR: 3294s, 3039w, 3002m, 2981m, 2928m, 1663vs, 1643vs, 1594m, 1532s, 1493s, 
1471m,  1394m,  1372s,  1360m,  1288m,  1221m,  1203m,  1111m,  930m,  916m,  775m,  715s, 
645m.  1H-NMR: 7.80 (br.  s, NH); 7.65–7.45 (m, 5 arom. H); 3.51 (MeN); 2.10, 1.68 (2s, 2 
Me2C).  13C-NMR: 179.6, 175.0 (2s, 2 CO); 144.9 (s, arom. C); 129.4, 128.5, 128.1  (3d, 5 
arom. CH); 62.5, 59.5 (2s, 2 Me2C); 41.5 (q, MeN); 32.0, 25.0 (2q, 2  Me2C). CI-MS: 341 
(100, [M+H]+). Anal. calc. for C15H21BrN2O2 (341.24): C 52.80, H 6.20, N 8.21, Br 23.42; 
found: C 52.73, H 6.24, N 8.22, Br 23.30. 
7.2.  Attempted Synthesis  of  2-Mercapto-2-methyl-N-[1-methyl-1-(N-methyl-N-
phenylcarbamoyl)ethyl]propionamide (29).  According to [25], to  a soln.  of  31 (1.0 g,  2.9 
25
mmol) in DMF (6.3 ml) was added a soln. of Na3PO3S.12 H2O (2.3 g, 5.8 mmol) in H2O (31.5 
ml). The mixture was stirred for 5 h, then the pH was lowered to 4.0 by addition of 3.5proz. 
HCl,  and stirring  was continued overnight.  The  mixture  was extracted  with  CH2Cl2 (3×), 
washed with brine, and dried (MgSO4). The filtered org. soln. was evaporated and the residue 
dried  i.HV  to  yield  210  mg  (27.5%)  of  2-Methyl-N-[1-methyl-1-(N-methyl-N-
phenylcarbamoyl)ethyl]acrylamide (32) as a colorless solid. 
Recrystallization  from MeOH/hexane  gave  colorless  crystals  suitable  for  an  X-ray 
crystal-structure determination.
7.3.  Synthesis  of  2-Mercapto-2-methyl-N-[1-methyl-1-(N-methyl-N-
phenylcarbamoyl)-ethyl]propionamide (29). According to GP 1: 167.2 mg (1.4 mmol) of 2-
mercapto-2-methylpropionic acid (33), which was prepared from 30 according to the protocol 
described in [25], in MeCN (20 ml), 242 mg (1.4 mmol) of 2b, 16 h at r.t. Purification by CC 
(SiO2,  CH2Cl2/Et2O  2:1)  and  dried  i.HV.  Yield:  389  mg  (95%)  of  29.  M.p.  140–141°. 
Colorless  solid.  IR:  3421s,  2927s,  1655vs,  1624vs,  1615s,  1516s,  1466vs,  1391s,  1372m, 
1281m, 1245m, 1225m, 1152m, 942m, 815m, 775m, 758s, 691s, 604s. 1H-NMR: 7.43 (s, NH); 
7.41–7.23 (m, 5 arom. H); 3.27 (s, MeN); 1.49, 1.48 (2s, 2 Me2C); 1.44 (br. s, SH). 13C-NMR: 
173.5, 173.1 (2s, 2 CO); 144.7 (s, arom. C); 129.4, 128.5, 127.9 (3d, 5 arom. CH); 58.2, 47.5 
(2s, 2 Me2C); 41.5 (q, MeN); 29.8, 25.7 (2q, 2 Me2C). CI-MS: 295 (100, [M+H]+), 188 (25, 
[C8H14NOS]+), 108 (26, [C7H8N]+). Anal. calc. for C15H22NO2S (294.41): C 61.19, H 7.53, N 
9.52, S 10.89; found: C 61.30, H 7.27, N 9.54, S 10.71.
7.4.  Attempted Cyclization of  29. According to  GP 2, a stirred suspension of  29 (90 
mg, 0.32 mmol) in dry toluene (15 ml) was heated to 100° under N2. An intense stream of dry 
HCl-gas was bubbled through the soln. for 15 min. Then, the soln. was purged with N2 for 30 
min to remove remaining HCl, toluene was evaporated, and THF/Et2O 1:1 (20 ml) was added 
to the residue. After 30 min of stirring at r.t., the suspension was filtered, and the solvent was 
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evaporated leading to a solid crude product, which was purified by prep. TLC (SiO2, CH2Cl2/
Et2O 2:1). Yield: 40 mg (60%) of 2-[(2-mercapto-2-methylpropanoyl)amino]-isobutyric acid 
(34).  Colorless  solid.  IR:  3330s,  3039w,  2987m,  2968m,  2924s,  2854m,  1744w,  1655vs, 
1624vs, 1592s, 1530vs, 1495s, 1469m, 1381s, 1369s, 1356m, 1276m, 1221m, 1040m, 1022m, 
974m, 890m, 776s, 706s, 699s.  1H-NMR: 7.78 (br. s, NH); 2.74, 2.65 (2s, 2 Me2C); 1.24 (s, 
SH).  13C-NMR: 175.4, 173.0 (2s, 2 CO); 58.6, 57.3 (2s, 2 Me2C); 36.2, 31.1 (2q, 2  Me2C). 
Anal. calc. for C8H15NO3S (205.28): C 46.81, H 7.37, N 6.82, S 15.62; found: C 46.73, H 
7.25, N 6.90, S 15.75.
8.  X-Ray Crystal-Structure Determination of 3aa, 4aa,  10a, 11a,  23,  26,  32,  and 34 
(Table  2 and  Figs.  1 –  5)7).  All  measurements,  with  the  exception  of  those  of  23,  were 
performed on a Nonius KappaCCD diffractometer [29] using graphite-monochromated MoKα 
radiation (λ 0.71073 Å) and an Oxford Cryosystems Cryostream 700 cooler. Data reduction 
was performed with  HKL Denzo  and  Scalepack [30]. In the case of  23, the measurements 
were  made  on  a  Rigaku  AFC5R  diffractometer  using  graphite-monochromated  MoKα 
radiation  (λ 0.71073  Å)  and  a  12kW  rotating  anode  generator.  The  data  collection  and 
refinement parameters are given in Table 2, and views of the molecules are shown in Figures  
1–5.  The  intensities  were  corrected  for  Lorentz and  polarization  effects,  and  absorption 
corrections based on the multi-scan method [31] were applied in the cases of  10a,  11a,  26, 
and  34. The structures of 3aa,  10a,  11a,  23,  26,  32, and  34 were solved by direct methods 
using SIR92 [32] and those of  4aa and the second polymorph of  10a by using SHELXS97 
[33], which revealed the positions of all non-H-atoms. In the case of the second polymorph of 
10a and  26, there are two and three symmetry-independent molecules, respectively,  in the 
7 ) CCDC-789182–789190 contain the supplementary crystallographic data for this paper. 
These data  can be obtained free of charge from the  Cambridge Crystallographic Data 
Centre via http://www.ccdc.cam.ac.uk/data_request/cif.
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asymmetric  unit.  The  atomic  coordinates  for  these  structures  were  tested  carefully  for  a 
relationship from a higher symmetry space group using the program PLATON [34], but none 
could be found.  In  the case of  11a,  the molecule  sits  across  a  crystallographic  centre  of 
inversion, so that the O- and NH-groups are necessarily disordered with equal site occupation 
factors of 0.5. The non-H atoms in each structure were refined anisotropically, except for the 
N-atom in 11a, which was refined isotropically. The hydroxy-, amide- (except in 23, 26, and 
32),  and  sulfide  H-atoms  were  placed  in  the  positions  indicated  by a  difference  electron 
density map and their positions were allowed to refine with individual isotropic displacement 
parameters. All other H-atoms were fixed in geometrically calculated positions and each was 
assigned a fixed isotropic displacement parameter with a value equal to 1.2Ueq of its parent 
C-atom.  The refinement of each structure was carried out on F using full-matrix least-squares 
procedures,  which minimized  the function  Σw(Fo– Fc)2.  A correction  for secondary 
extinction was applied in the cases of 3aa and 10a (polymorph 1), 32, and 34. Neutral atom 
scattering factors for non-H-atoms were taken from [35a], and the scattering factors for H-
atoms were  taken from  [36].  Anomalous  dispersion effects  were included in  Fc [37];  the 
values for f ' and f " were those of [37b]. The values of the mass attenuation coefficients are 
those  of  [35c].  All  calculations  were  performed  using  the  teXsan [38] crystallographic 
software package.
Table 2. Crystallographic Data for Compounds 3aa, 4aa, 10a, 11a, 23, 26, 32, and 34
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Legends
Fig. 1. ORTEP Plot [18] of the molecular structure of 3aa (50% probability ellipsoids, 
arbitrary numbering of the atoms)
Fig. 2. ORTEP Plots [18] of the molecular structures of a) 4aa, b) 10a (polymorph 1), 
and c) 11a (50% probability ellipsoids, arbitrary numbering of the atoms)
Fig. 3. ORTEP Plot [18] of the molecular structure of 23 (50% probability ellipsoids, 
arbitrary numbering of the atoms)
Fig. 4.  ORTEP Plot [18]  of the molecular structure of one of the three independent  
molecules of 26 (50% probability ellipsoids, arbitrary numbering of the atoms)
Fig. 5.  Plots [18]  of the molecular structures of  a)  32 and b)  34 (50% probability 
ellipsoids, arbitrary numbering of the atoms)
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Table 1. Characteristic Spectroscopic Data of Compounds 4a, 10, and 11
Compound
IR (KBr) [cm–1]a)
C(2)=O         C(5)=O
13C-NMR (CDCl3) [ppm]
  C(2)              C(5)
EI-MS 
M+. [m/z (%)]
4aa 1743 (1750)  1677 (1680)  170.2            169.8 172 (100)b)
4ab 1746 (1748)  1686 (1680)  169.5            166.2 233 (18) [1b]
4ac 1747 (1740)  1682 (1690)  169.1            165.3 219 (19) [1b]
10a 1738              -  169.4            200.5 188 (100)b)
10b 1749              -  168.3            193.7 249 (100)
10c 1742              -  169.7            192.7 235 (100)
12a -                     -  216.8            199.9 203 (7)
12b -                     -  215.2            193.3 265 (4)
  
  a) Values in brackets from [1b]; b) CI-MS (NH3); [M + 1]+        
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Table 2.  Crystallographic Data for Compounds 3aa, 4aa, 10a, 11a, 23, 26, 32, and 34
__________________________________________________________________________________
3aa 4aa 10a (polymorph 1)
__________________________________________________________________________________
Crystallized from MeCN toluene toluene
Empirical formula C15H22N2O3 C8H13NO3 C8H13NO2S
Formula weight 278.35 171.19 187.26
Crystal color, habit colorless, prism colorless, prism colorless, prism
Crystal dimensions [mm] 0.25 × 0.30 × 0.35 0.12 × 0.12 × 0.20 0.10 × 0.15 × 0.30
Temperature [K] 160(1) 160(1) 160(1)
Crystal system monoclinic monoclinic monoclinic
Space group P21/c P21/n P21/n
Z 4 4 4
Reflections for cell determination 4594 2117 56335
2θ range for cell determination [°] 4 – 60 2 – 55 2 – 60
Unit cell parameters a [Å] 5.8729(1) 7.9778(4) 5.6490(1)
b [Å] 19.2439(4) 5.9714(4) 22.0010(4)
c [Å] 13.6467(3) 18.626(1) 8.2026(1)
α [°] 90 90 90
β [°] 93.8172(8) 94.380(3) 108.7734(8)
γ [°] 90 90 90
V [Å3] 1538.89(5) 884.7(1) 965.21(3)
Dx [g cm–1] 1.201 1.285 1.289
µ(MoKα) [mm–1] 0.0838 0.0981 0.297
Scan type φ and ω ω φ and ω
2θ(max) [°] 60 55 60
Transmission factors (min; max) - - 0.843; 0.955
Total reflections measured 32625 11734 22304
Symmetry independent reflections 4478 2019 2808
Reflections used [I > 2σ(I)] 3148 1319 2316
Parameters refined 190 113 114
Final R(F) 0.0761 0.0571 0.0583
wR(F) 0.0765 0.0602 0.0739
Weighting parameter [a]a) 0.01 0.015 0.005
Goodness of fit 3.247 2.058 4.197
Secondary extinction coefficient 4.9(9) × 10–6 - 6(2) × 10–6
36
Final ∆max/σ 0.0002 0.002 0.0002
∆ρ (max; min) [e Å–3] 0.39; –0.44 0.29; –0.27 0.35; –0.30
a) w–1 = σ 2(Fo) + (aFo)2 
Table 2.  Crystallographic Data for Compounds 3aa, 4aa, 10a, 11a, 23, 26, 32, and 34 
(continued)
__________________________________________________________________________________
10a (polymorph 2) 11a 23
__________________________________________________________________________________
Crystallized from toluene toluene hexane
Empirical formula C8H13NO2S C8H13NOS2 C24H30N2O4S
Formula weight 187.26 203.32 442.57
Crystal color, habit colorless, prism yellow, prism colorless, prism
Crystal dimensions [mm] 0.20 × 0.20 × 0.25 0.08 × 0.20 × 0.28 0.20 × 0.40 × 0.50
Temperature [K] 160(1) 160(1) 213(1)
Crystal system triclinic monoclinic monoclinic
Space group P P21/c C2/c
Z 4 2 8
Reflections for cell determination 31739 25594 25
2θ range for cell determination [°] 4 – 60 2 – 55 30 – 39
Unit cell parameters a [Å] 8.7363(1) 5.6152(2) 24.388(2)
b [Å] 11.3121(2) 14.8426(5) 7.002(4)
c [Å] 11.3342(1) 6.3708(2) 27.823(2)
α [°] 66.6701(6) 90 90
β [°] 70.2665(6) 111.185(1) 97.336(6)
γ [°] 71.5837(5) 90 90
V [Å3] 946.37(2)(1) 495.09(3) 4712(2)
Dx [g cm–1] 1.314 1.364 1.248
µ(MoKα) [mm–1] 0.303 0.491 0.169
Scan type φ and ω φ and ω ω
2θ(max) [°] 60 55 55
Transmission factors (min; max) 0.822; 0.943 0.828; 0.967 -
37
Total reflections measured 39683 9550 5985
Symmetry independent reflections 5530 1122 5404
Reflections used [I > 2σ(I)] 4520 997 3612
Parameters refined 225 63 280
Final R(F) 0.0410 0.0405 0.0520
wR(F) 0.0507 0.0521 0.0482
Weighting parameter [a]a) 0.008 0.007 0.005
Goodness of fit 2.874 2.920 1.886
Secondary extinction coefficient - - -
Final ∆max/σ 0.002 0.0002 0.0008
∆ρ (max; min) [e Å–3] 0.50; –0.33 0.28; –0.27 0.51; –0.28
a) w–1 = σ 2(Fo) + (aFo)2 
Table 2.  Crystallographic Data for Compounds 3aa, 4aa, 10a, 11a, 23, 26, 32, and 34 
(continued)
__________________________________________________________________________________
26 32 34
__________________________________________________________________________________
Crystallized from hexane/AcOEt MeOH/hexane toluene
Empirical formula C15H22N2O2S C15H20N2O2 C8H15NO3S
Formula weight 294.41 260.33 205.27
Crystal color, habit colorless, prism colorless, plate colorless, prism
Crystal dimensions [mm] 0.22 × 0.27 × 0.32 0.13 × 0.30 × 0.30 0.20 × 0.20 × 0.25
Temperature [K] 160(1) 160(1) 160(1)
Crystal system monoclinic monoclinic monoclinic
Space group P21/n Cc P21/n
Z 12 4 4
Reflections for cell determination 104075 2126 17370
2θ range for cell determination [°] 4 – 60 4 – 60 4 – 60
Unit cell parameters a [Å] 10.0643(1) 8.8101(1) 10.3232(2)
b [Å] 11.9354(1) 17.8470(3) 9.5082(2)
c [Å] 40.4795(3) 9.9602(2) 11.1870(2)
α [°] 90 90 90
38
β [°] 96.5109(3) 114.0449(7) 112.5896(7)
γ [°] 90 90 90
V [Å3] 4831.09(7) 1430.19(4) 1013.82(3)
Dx [g cm–1] 1.214 1.209 1.345
µ(MoKα) [mm–1] 0.204 0.0808 0.296
Scan type φ and ω ω φ and ω
2θ(max) [°] 60 60 60
Transmission factors (min; max) 0.764; 0.961 - 0.904; 0.946
Total reflections measured 70128 19923 28726
Symmetry independent reflections 13807 4058 2969
Reflections used [I > 2σ(I)] 7052 3575 2081
Parameters refined 553 175 127
Final R(F) 0.0449 0.0424 0.0333
wR(F) 0.0494 0.0420 0.0427
Weighting parameter [a]a) 0.005 0.005 0.005
Goodness of fit 1.256 2.501 1.043
Secondary extinction coefficient - 4.2(6) × 10–6 4(5) × 10–7
Final ∆max/σ 0.0004 0.0006 0.0003
∆ρ (max; min) [e Å–3] 0.29; –0.36 0.18; –0.18 0.29; –0.29
a) w–1 = σ 2(Fo) + (aFo)2 
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